Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
- - - - - - - 319K
0.84%0.87%37.01x5.36x7x23.88x29.19x 44.96B
1.43%1.53%17.02x1.65x1.9x8.99x11.67x 33.53B
0.9%1.02%26.7x2.97x3.28x16.8x21.39x 11.67B
0.73%0.6%24.25x3.99x4.23x15.77x19.16x 11.62B
3.51%3.69%19.34x3.21x3.34x12.18x14.74x 8.97B
5.33%5.7%8.14x1.4x1.9x4.98x6.03x 6.89B
3.63%3.5%14.75x1.29x1.94x7.33x9.82x 6.55B
0.25%0.27%32.55x5.76x3.7x15.73x17.37x 6.32B
1.05%1.27%37.49x8.62x7.17x26.58x29.68x 4.1B
1.39%1.79%15.33x0.71x1.94x8.18x11.13x 3.89B
4.18%5.37%12.69x2.13x2.14x10.08x10.45x 3.18B
2.84%3.15%21.14x5.68x6.64x18.87x20.41x 2.94B
2.84%2.91%14.03x2.82x3.25x12.12x13.39x 2.78B
Average 2.22% 2.44% 21.57x 3.51x 3.73x 13.96x 16.50x 10.53B
Weighted average by Cap. 1.61% 1.72% 25.20x 3.59x 4.19x 15.65x 19.13x
Generic Pharmaceuticals
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!